|
Mg OSTEOCRETE Post-Treatment Outcomes
RECRUITINGSponsored by Santiago Lozano-Calderon
Actively Recruiting
SponsorSantiago Lozano-Calderon
Started2025-03-17
Est. completion2025-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06720142
Summary
Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * 18 years of age and older on the day of surgery * has received or will receive Mg OSTEOCRETE as a component of their treatment at this institution in accordance with Instructions for Use for the implanted product * Mg OSTEOCRETE is indicated for one of the following reasons: 1. as a bone void filler following bone tumor resection, or; 2. as an augment for defects causing aseptic loosening of orthopaedic implants, or; 3. to help substitute bone for trauma-related conditions Exclusion Criteria: * any contraindication as per Instructions for Use for Mg OSTEOCRETE
Conditions4
Aseptic Loosening of Orthopaedic HardwareCancerCancer of BoneTrauma
Locations1 site
Massachusetts General Hospital
Boston, Massachusetts, 02114
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorSantiago Lozano-Calderon
Started2025-03-17
Est. completion2025-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06720142